“Customers want solutions that reduce the time from discovery to delivery of a new chemical or biological entity,” said Nick Roelofs, Ph.D., president, Agilent Life Sciences Group. “By providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback